Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Pérez-Molina JA, Mora Rillo M, Suárez-Lozano I, Casado-Osorio JL, Teira Cobo R, Rivas González P, Pedrol Clotet E, Hernando-Jerez A, Domingo P, Barquilla Díaz E, Esteban H, González-García J.
Response to Combined Antiretroviral Therapy According to Gender and Origin in a Cohort of Naive HIV-Infected Patients: GESIDA-5808 Study
HIV CLINICAL TRIALS . 13(3): 131-141. Nº de citas: 11
-
Odolini S, Parola P, Gkrania-Klotsas E, Caumes E, Schlagenhauf P, López-Vélez R, Burchard GD, Santos-O'Connor F, Weld L, von Sonnenburg F, Field V, de Vries P, Jensenius M, Loutan L, Castelli F.
Travel-related imported infections in Europe, EuroTravNet 2009
CLINICAL MICROBIOLOGY AND INFECTION . 18(5): 468-474. Nº de citas: 49
-
Moreno S.
Earlier initiation of antiretroviral therapy after start of antituberculosis therapy reduced mortality in HIV
ANNALS OF INTERNAL MEDICINE . 156(6): .
-
Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G, CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group.
Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
Plos One . 7(3): . Nº de citas: 26
-
Miró JM, Blanes M, Norman F, Martín-Dávila P.
Infections in solid organ transplantation in special situations: HIV-infection and immigration.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 30 Suppl 2: 76-85.
-
Macías J, Neukam K, Mallolas J, López-Cortés LF, Cartón JA, Domingo P, Moreno S, Iribarren JA, Clotet B, Crespo M, de Los Santos I, Ortega E, Knobel H, Jiménez-Expósito MJ, Pineda JA.
Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients
HIV CLINICAL TRIALS . 13(2): 61-69. Nº de citas: 16
-
Fortún J, Ruiz I, Martín-Dávila P, Cuenca-Estrella M.
Fungal infection in solid organ recipients.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 30 Suppl 2: 49-56.
-
Pérez-Molina JA, Díaz-Menéndez M, Plana MN, Zamora J, López-Vélez R, Moreno S.
Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 67(2): 312-321. Nº de citas: 15
-
Pineda JA, Neukam K, Mallolas J, López-Cortés LF, Cartón JA, Domingo P, Moreno S, Iribarren JA, Clotet B, Crespo M, de Los Santos I, Ortega E, Knobel H, Jiménez-Expósito MJ, Macías J.
Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis
JOURNAL OF INFECTION . 64(2): 204-211. Nº de citas: 7
-
Fernàndez-Sabé N, Cervera C, Fariñas MC, Bodro M, Muñoz P, Gurguí M, Torre-Cisneros J, Martín-Dávila P, Noblejas A, Len O, García-Reyne A, Del Pozo JL, Carratalà J.
Risk Factors, Clinical Features, and Outcomes of Toxoplasmosis in Solid-Organ Transplant Recipients: A Matched Case-Control Study
CLINICAL INFECTIOUS DISEASES . 54(3): 355-361. Nº de citas: 80
-
Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A.
Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses.
JOURNAL OF CLINICAL MICROBIOLOGY . 50(2): 407-413. Nº de citas: 34
-
Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, Gatell J, d'Arminio Monforte A, Phillips A, Lundgren JD, Kirk O, EuroSIDA study group.
Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy
AIDS . 26(3): 315-323. Nº de citas: 26
-
Tejada Evans AD, Ortega-Sánchez G, Moreno Guillén S.
Síndrome de coloración púrpura de la orina.
REVISTA CLINICA ESPANOLA . 212(1): .
-
Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A, Gatell J, Fisher M, Trocha H, Rakhmanova A, Lundgren JD.
The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression
ANTIVIRAL THERAPY . 17(7): 1291-1300. Nº de citas: 6
-
Jarrin I, Pantazis N, Gill MJ, Geskus R, Perez-Hoyos S, Meyer L, Prins M, Touloumi G, Johnson A, Hamouda O, de Olalla PG, Porter K, del Amo J.
Uptake of Combination Antiretroviral Therapy and HIV Disease Progression According to Geographical Origin in Seroconverters in Europe, Canada, and Australia
CLINICAL INFECTIOUS DISEASES . 54(1): 111-118. Nº de citas: 15
-
Molina JM, Lamarca A, Andrade-Villanueva J, Clotet B, Clumeck N, Liu YP, Zhong L, Margot N, Cheng AK, Chuck SL, Study 145 Team.
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
LANCET INFECTIOUS DISEASES . 12(1): 27-35. Nº de citas: 138
-
Monge-Maillo B, López-Vélez R.
Migration and malaria in europe.
Mediterranean journal of hematology and infectious diseases . 4(1): .
-
Díaz-Menéndez M, Pérez-Molina JA, Norman FF, Pérez-Ayala A, Monge-Maillo B, Fuertes PZ, López-Vélez R.
Management and Outcome of Cardiac and Endovascular Cystic Echinococcosis
PLOS NEGLECTED TROPICAL DISEASES . 6(1): . Nº de citas: 19